Research Highlights

Since its inception, the Vancouver Prostate Centre’s research activities have led to valuable new insights, treatments, and intellectual property:

  • We were instrumental in establishing the use of Intermittent Androgen Ablation Therapy as a standard treatment modality for prostate cancer
  • In 2015, the Centre developed a potential new therapeutic that is designed to outsmart cancer and inhibit tumour growth by disabling the androgen receptor where it binds to a specific part of the DNA that is not prone to mutation, opening the possibility of designing drugs that could be effective for a long time
    • The drug candidate was developed using computer-aided drug design (CADD), a technology that evaluates a database of millions of different molecules to identify a handful which may work well as possible treatments
  • My Precision Oncology Program (MyPOP), made possible by infrastructural investment from the Canadian Foundation for Innovation and a generous donation by a private donor, allows for the routine linking of genomic sequencing data with real-time clinical decision making
  • Our annual knowledge output averages 120 peer-reviewed publications and 150 presentations at conferences
  • Since 2008, our Centre has been awarded over $125 million in peer-reviewed research grants from regional, national and international agencies
  • Since 2008 we have initiated 138 new Clinical Trials enrolling 2,886 patients
  • We have a strong record of recruitment of senior staff and faculty promotions
  • The Centre currently had 37 post-doctoral fellows, 35 Ph.D. students and 13 Masters students
  • Since 2008 we have negotiated 56 new contract research agreements with pharmaceutical and biotech companies including Pfizer, Takeda, AstraZeneca, Bayer and Janssen
  • Intellectual Property Activities since 2008 include
    •  294 patent filed/issued
    •  9 Licensing Agreements of IP with Industry (8 drug, 1 biomarker)
      • Our 2015 licensing to Roche was UBC's largest out-licensing deal to date
  • Discoveries at our Centre have led to the creation of several biotech companies, including OncoGeneX (now Achieve Life Sciences) and Aquinox

 

Page updated November 1, 2018

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Step  Up Challenge 2019

Step Up Challenge Vancouver - March 10, 2019

Donations are still being accepted for Prostate Cancer Canada's Step Up Challenge fundraiser, which took place on Sunday March 10.   Click here to donate to The Vancouver Prostate Centre team

10th Anniversary Ride to Live

West Coast Motorcycle Ride To Live: May 26th

The 10th Anniversary West Coast Motorcycle Ride to Live is taking place in Vancouver and the Fraser Valley on May 26 (Victoria date to be finalized), with details on the event and how to register on the event website.  This fundraiser for Prostate Cancer Foundation BC includes a 50/50 raffle open to all BC residents over age 19.

Employment

Work at the Vancouver Prostate Centre

Friday, January 25, 2019

Dr. Wang awarded CIHR project grant; three trainees awarded PCF-BC research grants

Dr. Wang and laboratory
Friday, February 15, 2019

Dr. Zoubeidi interviewed for International Day of Women and Girls in Science

Dr. Amina Zoubeidi